SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-024371
Filing Date
2009-07-22
Accepted
2009-07-22 16:31:35
Documents
8
Period of Report
2009-07-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y78387e8vk.htm 8-K 19839
2 EX-99.1 y78387exv99w1.htm EX-99.1 75266
3 EX-99.2 y78387exv99w2.htm EX-99.2 16268
4 EX-99.3 y78387exv99w3.htm EX-99.3 13915
5 GRAPHIC y78387y7838701.gif GRAPHIC 6473
6 GRAPHIC y78387y7838702.gif GRAPHIC 4397
7 GRAPHIC y78387y7838703.gif GRAPHIC 3061
8 GRAPHIC y78387y7838704.gif GRAPHIC 4705
  Complete submission text file 0000950123-09-024371.txt   153208
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 09957389
SIC: 2835 In Vitro & In Vivo Diagnostic Substances